leuprolide

(redirected from Lupron)
Also found in: Medical.

leu·pro·lide

 (lo͞o′prō-līd′)
n.
A drug that is a synthetic polypeptide analog of naturally occurring gonadotropin-releasing hormone, C29H84N16O12, used in its acetate form to treat advanced prostate cancer.

Mentioned in ?
References in periodicals archive ?
In conjunction with the trial, the study will determine the safety and evaluate the PK/PD metrics of two different oral doses of the company's Ovarest in comparison to the leuprolide formulation approved for the treatment of endometriosis, Lupron Depot 3.
Lupron was well-tolerated and resulted in normalized erections within 10-21 days.
After that, she typically injects Lupron, a hormone approved to treat advanced prostate cancer.
8220;I have changed my diet to a strict organic vegan diet and have responded well to hormone drugs Lupron and Casodex.
The two laughed as they recalled part of their treatment involving Lupron, a hormone that helps fight the growth of cancer by reducing testosterone levels.
Two days after I begin my period, I start taking birth control; after about a week I take shots of Lupron to suppress my regular cycle.
In 2010, Lupron and Eligard, the most expensive drugs, were administered about twice as often as the least expensive drug, Trelstar.
GlobalData has released its new PharmaPoint Drug Evaluation report, Lupron Depot (Prostate Cancer) - Forecast and Market Analysis to 2022.
The research-based pharmaceutical company has nearly $18 billion in annual revenue today and will have a sustainable portfolio of market-leading brands, including Humira, Lupron, Synagis, Kaletra, Creon and Synthroid.
The list includes glucocorticoids and related immunosuppressants, antidiabetic drugs, lithium, Depo-Provera and other contraceptives, cyclooxygenase inhibitors, proton pump inhibitors (pharmaceutical antacids), total parenteral nutrition (this means not administered via the alimentary canal), aromatase inhibitors (letrozole, exemestane, anastrozole), gonadotropin-releasing hormone agonists (Lupron, Lupron Depot, LH-RH agonists, leuprolide), immunosuppressants, anticonvulsants (phenobarbital, phenytoin), cytotoxic drugs, and selective serotonin reuptake inhibitors (SSRIs), which lead to the issue of stress and depression.
Administration of an injection that blocks gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus is the most commonly prescribed therapy (leuprolide acetate, Lupron Depot-PED).
GTx aims to begin two mid-stage trials of the drug early next year, one in patients diagnosed with advanced prostate cancer and another in those who have failed to respond to injectable drugs, like Lupron, used to treat the cancer by reducing the amount of testosterone made by the body.